Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC5A1 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → SLC5A1 |
| (<<) ATP10B → SLC5A1 |
| (<<) CXADR → SLC5A1 |
| (<<) ELF3 → SLC5A1 |
| (<<) F2RL1 → SLC5A1 |
| (<<) GDF15 → SLC5A1 |
| (<<) GOT2 → SLC5A1 |
| (<<) GPX2 → SLC5A1 |
| (<<) ITGA6 → SLC5A1 |
| (<<) KCNN4 → SLC5A1 |
| (<<) MST1R → SLC5A1 |
| (<<) NR3C1 → SLC5A1 |
| Downstream (Children) |
|---|
| SLC5A1 → COTL1 (>>) |
| SLC5A1 → ELF2 (>>) |
| SLC5A1 → ETS2 (>>) |
| SLC5A1 → KCNJ2 (>>) |
| SLC5A1 → KRT6B (>>) |
| SLC5A1 → PIK3CD (>>) |
| SLC5A1 → PYGB (>>) |
| SLC5A1 → SLC25A37 (>>) |
| SLC5A1 → TRIB1 (>>) |
